Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

Oesterling, 1991, Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate, J Urol, 145, 907, 10.1016/S0022-5347(17)38491-4

Stamey, 1987, Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate, N Engl J Med, 317, 909, 10.1056/NEJM198710083171501

Brawer, 1989, PSA in the screening, staging and follow-up of early-stage prostate cancer. A review of recent developments, World J Urol, 7, 7, 10.1007/BF01576837

Catalona, 1991, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702

Benson, 1992, Prostate-specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer, J Urol, 147, 815, 10.1016/S0022-5347(17)37393-7

Partin, 1990, Prostate-specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia, J Urol, 143, 747, 10.1016/S0022-5347(17)40079-6

Carter, 1992, Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease, JAMA, 267, 2215, 10.1001/jama.267.16.2215

Carter, 1992, Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease, Cancer Res, 52, 3323

Stein, 1992, Prostate-specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer, J Urol, 147, 942, 10.1016/S0022-5347(17)37429-3

Partin, 1993, Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years, Urol Clin North Am, 20, 713, 10.1016/S0094-0143(21)00924-1

Zagars, 1991, Prostatespecific antigen and external beam radiation therapy in prostate cancer, Cancer, 67, 412, 10.1002/1097-0142(19910115)67:2<412::AID-CNCR2820670216>3.0.CO;2-R

Schellhammer, 1993, Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate, Urology, 42, 13, 10.1016/0090-4295(93)90325-5

Kaplan, 1990, Prostate-specific antigen after irradiation for prostatic carcinoma, J Urol, 144, 1172, 10.1016/S0022-5347(17)39684-2

Lange, 1990, The effect of radiation therapy after radical prostatectomy in patients with elevated prostate-specific antigen levels, J Urol, 144, 927, 10.1016/S0022-5347(17)39624-6

Link, 1991, Adjuvant radiation therapy in patients with detectable prostate-specific antigen following radical prostatectomy, J Urol, 145, 532, 10.1016/S0022-5347(17)38388-X

Stamey, 1989, Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV Anti-androgen treated patients, J Urol, 141, 1088, 10.1016/S0022-5347(17)41177-3

Goldrath, 1989, Prostate-specific antigen: not detectable despite tumor progression after radical prostatectomy, J Urol, 142, 1082, 10.1016/S0022-5347(17)38998-X

Takayama, 1992, Recurrent prostate cancer despite undetectable prostate-specific antigen, J Urol, 148, 1541, 10.1016/S0022-5347(17)36963-X

Morton, 1991, Cancer control following anatomical radical prostatectomy: an interim report, J Urol, 145, 1197, 10.1016/S0022-5347(17)38574-9

Lindstrom, 1988, Newton-Raphson and EM. algorithms for linear mixed-effects models for repeatedmeasures data, J Am Stat Assoc, 83, 1014, 10.2307/2290128

Catalona, 1993, Value of measurements of the rate of change of serum PSA levels in prostate cancer screening (Abstr), J Urol, 149, 300A

Carter, 1988, Prostate cancer: the magnitude of the problem in the United States, 1

Walsh, 1987, Adjuvant radiotherapy after radical prostatectomy: is it indicated?, J Urol, 138, 1427, 10.1016/S0022-5347(17)43662-7

Anscher, Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy, with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule, J Urol, 138, 1407, 10.1016/S0022-5347(17)43656-1

Lange, 1990, The effect of radiation therapy after radical prostatectomy in patients with elevated prostate-specific antigen levels, J Urol, 144, 927, 10.1016/S0022-5347(17)39624-6

Montie, 1990, Significance and treatment of positive margins or seminal vesicle invasion after radical prostatectomy, Urol Clin North Am, 17, 803, 10.1016/S0094-0143(21)01374-4

Link, 1991, Adjuvant radiation therapy in patients with detectable prostate-specific antigen following radical prostatectomy, J Urol, 145, 532, 10.1016/S0022-5347(17)38388-X

Schild, 1992, The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy, Int J Radiat Oncol Biol Phys, 23, 141, 10.1016/0360-3016(92)90553-T

Danella, 1993, Detectable prostate-specific antigen levels following radical prostatectomy: relationship of doubling time to clinical outcome (abstr), J Urol, 149, 447A